Nalaganje...

Delayed CTLA4-Ig treatment reverses ongoing alloantibody responses and rescues allografts from acute rejection

Antibody-mediated rejection has emerged as the leading cause of late graft loss in kidney transplant recipients, and inhibition of donor-specific antibody production should lead to improved transplant outcomes. The fusion protein CTLA4-Ig blocks T-cell activation and consequently inhibits T-dependen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Transplant
Main Authors: Young, James S., Chen, Jianjun, Miller, Michelle L., Vu, Vinh, Tian, Changtai, Moon, James J., Alegre, Maria-Luisa, Sciammas, Roger, Chong, Anita S.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956497/
https://ncbi.nlm.nih.gov/pubmed/26928966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.13761
Oznake: Označite
Brez oznak, prvi označite!